GMO U.S. Value ETF (NYSEARCA:GMOV) Sees Large Decrease in Short Interest

GMO U.S. Value ETF (NYSEARCA:GMOV) was the recipient of a large decline in short interest in September. As of September 15th, there was short interest totaling 484 shares, a decline of 86.6% from the August 31st total of 3,614 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average trading volume of 28,429 shares, the short-interest ratio is currently 0.0 days.

GMO U.S. Value ETF Trading Up 0.6%

NYSEARCA:GMOV traded up $0.18 during trading hours on Friday, hitting $32.33. The stock had a trading volume of 3,486 shares, compared to its average volume of 16,250. The company has a market cap of $96.99 million, a PE ratio of 12.08 and a beta of 0.63. The business has a 50 day simple moving average of $32.28 and a two-hundred day simple moving average of $30.44. GMO U.S. Value ETF has a 1-year low of $25.66 and a 1-year high of $33.47.

GMO U.S. Value ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 1st. Stockholders of record on Tuesday, June 30th were paid a $0.1283 dividend. This represents a $0.51 annualized dividend and a dividend yield of 1.6%. This is a drop from GMO U.S. Value ETF’s previous quarterly dividend of $0.1690. The ex-dividend date was Tuesday, June 30th.

Institutional Investors Weigh In On GMO U.S. Value ETF

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Pathway Financial Advisors LLC bought a new stake in shares of GMO U.S. Value ETF during the 2nd quarter valued at about $246,000. Essential Partners LLC lifted its holdings in GMO U.S. Value ETF by 8.6% in the first quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock worth $1,692,000 after acquiring an additional 4,774 shares during the last quarter. Fifth Third Bancorp acquired a new position in GMO U.S. Value ETF in the first quarter valued at approximately $84,000. Kestra Private Wealth Services LLC bought a new position in GMO U.S. Value ETF during the 1st quarter worth $333,000. Finally, J.W. Cole Advisors Inc. grew its position in shares of GMO U.S. Value ETF by 128.7% during the fourth quarter. J.W. Cole Advisors Inc. now owns 28,510 shares of the company’s stock worth $784,000 after acquiring an additional 16,044 shares during the last quarter.

GMO U.S. Value ETF Company Profile

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.